Yongqian Q. Shu

No. 300 Guangzhou Road
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 389 publications

Sutetinib for Patients with Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase IIb Trial.

Sutetinib for Patients with Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase IIb Trial.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 16, 2026

Safety of fruquintinib mono- and combo therapy in metastatic colorectal cancer: real-world subgroup analysis from China.

Safety of fruquintinib mono- and combo therapy in metastatic colorectal cancer: real-world subgroup analysis from China.

Journal: Future oncology (London, England)
Published: May 28, 2026

A predictive model for immunotherapy efficacy in cancer based on dynamic changes of CD8+ T cells: a pan-cancer retrospective study.

A predictive model for immunotherapy efficacy in cancer based on dynamic changes of CD8+ T cells: a pan-cancer retrospective study.

Journal: Frontiers in immunology
Published: May 02, 2026

Efficacy and Safety of DVDMS-Photodynamic Therapy for Dysphagia in Advanced Esophageal Cancer: A Phase II Clinical Trial.

Efficacy and Safety of DVDMS-Photodynamic Therapy for Dysphagia in Advanced Esophageal Cancer: A Phase II Clinical Trial.

Journal: Cancer science
Published: April 20, 2026

Cancer cell-selective ectopic expression of CD20 as an antigen enables rituximab repurposing for solid tumour immunotherapy.

Cancer cell-selective ectopic expression of CD20 as an antigen enables rituximab repurposing for solid tumour immunotherapy.

Journal: Clinical and translational medicine
Published: April 14, 2026

Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant Non-Small Cell Lung Cancer: Final Analysis of the Phase 2, Single-Arm DESTINY-Lung05 Trial.

Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant Non-Small Cell Lung Cancer: Final Analysis of the Phase 2, Single-Arm DESTINY-Lung05 Trial.

Journal: Clinical lung cancer
Published: March 20, 2026

Distinct epidemiologic patterns of mesothelioma: evidence from a 16-year provincial cohort in China.

Distinct epidemiologic patterns of mesothelioma: evidence from a 16-year provincial cohort in China.

Journal: BMC cancer
Published: January 19, 2026

Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.

Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.

Journal: EMBO molecular medicine
Published: December 11, 2025

Rezivertinib in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study.

Rezivertinib in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study.

Journal: Cancer communications (London, England)
Published: November 29, 2025

Preliminary application of modified interposed jejunal anastomosis in digestive tract reconstruction following total laparoscopic proximal gastrectomy

Preliminary application of modified interposed jejunal anastomosis in digestive tract reconstruction following total laparoscopic proximal gastrectomy

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: November 25, 2025

IL-17 promotes H1299 cell proliferation via LINC01518/miR-20a-5p/E2F1 axis in non-small cell lung cancer.

IL-17 promotes H1299 cell proliferation via LINC01518/miR-20a-5p/E2F1 axis in non-small cell lung cancer.

Journal: Neoplasma
Published: November 11, 2025

Machine Learning-Based Prognostic Model for Gastric Cancer Using Integrated Multi-Omics Data.

Machine Learning-Based Prognostic Model for Gastric Cancer Using Integrated Multi-Omics Data.

Journal: Cancer investigation
Published: October 20, 2025
Showing 1-12 of 389

Last Updated: 09/26/2026